Investors > Corporate Governance

Corporate Documents

NASDAQ:OKYO

Annual reports

31 March 2024 (20-F)

31 March 2023 (20-F/A) Amended

31 March 2023 (20-F)

31 March 2023

31 March 2022 (20-F)

31 March 2022

31 March 2021

31 March 2020

31 March 2019

31 March 2018

31 March 2017

31 March 2016

31 March 2015

31 March 2014

31 March 2013

31 March 2012

31 March 2011

31 March 2010

31 March 2009

Interim Reports

30 September 2023

30 September 2022

30 September 2021

30 September 2020

30 September 2019

30 September 2018

30 September 2017

30 September 2016

30 September 2015

30 September 2014

30 September 2013

30 September 2012

30 September 2011

30 September 2010

30 September 2009

30 September 2008

Corporate Documents

Results of AGM 2023

Notice of AGM: December 2023

Registration Statement for former UK shareholders effective

Memorandum and Articles of Association Amended May 2023

Result of General Meeting 3.5.23

OKYO Circular April 2023 v.7

OKYO Pharma GM Proxy Form GM v.2

Notice of Intention To Delist From The London Stock Exchange

Code of Business Conduct

Results of AGM 2022

Notice of AGM: September 2022

Results of AGM 2021

Notice of AGM: September 2021

OKYO Prospectus

Result of AGM 2020

Memorandum and Articles of Incorporation

Notice of AGM: September 2020

Results of AGM 2020

Notice of Annual General Meeting 2020

Results of AGM 2018

Notice of Annual General Meeting 2018

Admission Prospectus to OKYO Pharma Ltd.

Cancellation of AIM Listing and Migration Circular

General Meeting Voting

Memorandum of Association Articles of Association

Proposed Disposal and Special Dividend, Change of Name and Notice of General Meeting